Search

Search Constraints

You searched for: Author/Creator DiPersio, John F.

Search Results

1. 3D tissue engineered plasma cultures support leukemic proliferation and induces drug resistance. Issue 10 (24th August 2021)

2. A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia. Issue 3 (3rd March 2016)

3. A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes. Issue 6 (12th May 2021)

4. A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndrome. Issue 11 (1st November 2016)

5. Allogeneic hematopoietic cell transplantation in morphologic leukemia‐free aplastic state. Issue 9 (19th July 2017)

7. BL‐8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open‐label safety and efficacy phase 2a study. Issue 8 (3rd December 2020)